Tuesday, June 14, 2016 5:03:03 PM
I've looked through past EAPH PRs to find out when they estimated we'd have Mexican approval for the cancer drugs and the women's health products.In a PR date 9/15/15 they stated: Ackerman Pharma believes the approval [for the cancer drugs] "can be obtained by the end of 2015 or shortly into the New Year...
In a letter to shareholders dated 10/7/15 EAPH stated the women's health products will "undergo a fast-track process... in order to shorten the normally long two-three year approvals process down to months."
Well, here we are 8-9 months later and we're still waiting on Mexican approval for these products. Without that approval this company becomes very questionable; with it there may be some potential for a share price increase.
Why is the company not updating us on this situation? Comments welcome.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM